跳至主要内容
临床试验/CTRI/2026/01/101461
CTRI/2026/01/101461尚未招募2 期

A RANDOMISED CONTROL TRIAL ON YAMANIPANCHAKA VATI AND DEVADARVYADI VATI IN THE MANAGEMENT OF GRAHNI ROGA W.S.R. IBS IN CHILDREN

Parul Kaushik1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2026年1月30日最近更新:
适应症
相关药物

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
150
试验地点
1
主要终点
From this clinical study, it is expected to have a better drug option out of these two that will be available

研究概览

简要总结

This study is proposed for Ph.D. research/ thesis work. Adolescence is a pivotal phase of growth and development, during which gastrointestinal problems, such as Grahani Roga, may arise. The primary causes of Grahani Roga in youngsters are the disturbance of Agni, either directly from exposure to various etiological factors or because to pre-existing Mandagni, exacerbated by inappropriate food selections. Symptoms of IBS have similarities with the symptoms of Grahani Dosha like, alternation in bowel habits (Muhur-baddha, Muhur-drava), stools mixed with mucus (Shleshma mal Pravritti) etc. The aspect of malabsorption and mal functioning of digestive fire stretched my interest to study on the topic effective management of grahani with special reference to IBS. Children are more delicate, having Alpa-Bala, Alpa-Satva and Aniyata-Agni, they are easily affected by favourable and unfavourable conditions like Mithya Ahara Vihara. Fast food and junk food consumption in the modern world, along with ongoing stress, further disrupts the digestive system and leads to a number of gastrointestinal tract-related illnesses, of which Grahani Roga is one of the most common.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
5.00 Year(s) 至 16.00 Year(s)(—)
性别
All

入选标准

  • •Subject of age group 5 year to 16 year.
  • •Subject suffering from symptoms of Grahani (mild to moderate IBS).

排除标准

  • •Subject Below age 5 year and Above 16 year of age.
  • •Subjects with severe diarrhea and dehydration.
  • •Subject with complications; Chronic disease.
  • •Subject with PEM/ SAM/MAM.
  • •Mentally retarded subjects.

结局指标

主要结局

From this clinical study, it is expected to have a better drug option out of these two that will be available

时间窗: The follow ups or outcomes are assessed at 0th day(baseline), 14th day, 28th day, 42nd day.

for Grahni Roga in children and will be most effective and have no side-effects.

时间窗: The follow ups or outcomes are assessed at 0th day(baseline), 14th day, 28th day, 42nd day.

次要结局

未报告次要终点

研究者

发起方
Parul Kaushik
申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

Parul Kaushik

Desh Bhagat Ayurvedic College

研究点 (1)

Loading locations...

相似试验